Therapeutic genome editing
Pro Research Analysisby 
Searched over 200M research papers
Therapeutic Genome Editing: Opportunities and Challenges
Introduction to Therapeutic Genome Editing
Therapeutic genome editing involves the precise manipulation of DNA sequences within cells to alter cell functions and treat genetic diseases. This technology, particularly through the use of CRISPR/Cas9, has shown immense potential in both understanding human genetics and curing genetic disorders . The ability to directly correct genetic mutations offers a promising avenue for treating diseases that are otherwise difficult to manage with traditional therapies .
Genome Editing Technologies
CRISPR/Cas9 and Other Nucleases
The CRISPR/Cas9 system has revolutionized genome editing due to its relative ease of use and cost-effectiveness compared to earlier technologies like zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) . These nucleases enable precise modifications of the genome, which can include the correction of disease-causing mutations, addition of therapeutic genes, or removal of deleterious sequences 36.
Mechanisms and Applications
Genome editing technologies work by creating double-strand breaks in DNA, which can then be repaired in a way that introduces desired genetic changes. This can be used to correct mutations, add new genes, or delete harmful sequences . Applications of these technologies span a wide range of therapeutic areas, including antiviral strategies, immunotherapies, and treatments for monogenic hereditary disorders .
In Vivo Delivery Systems
Challenges in Delivery
One of the major challenges in therapeutic genome editing is the delivery of editing tools into target cells. The large size, negative charge, and low membrane penetration ability of nucleases like CRISPR/Cas9 make in vivo delivery difficult . Effective delivery systems are crucial for the success of genome editing therapies .
Current Strategies
Various delivery methods are being explored, including viral vectors like adeno-associated viruses (AAV) and lentiviruses, as well as non-viral vectors such as lipid nanoparticles. These methods aim to improve the efficiency and specificity of delivery to target tissues while minimizing off-target effects and immunogenicity 410. Clinical trials are already testing these delivery strategies, with some showing promising results 27.
Ethical and Regulatory Considerations
Ethical Challenges
The rapid advancement of genome editing technologies raises significant ethical concerns. These include the potential for unintended genetic changes, the long-term effects of genome editing, and the ethical implications of editing the human germline . Ensuring responsible use of these technologies is paramount to prevent misuse and address public concerns.
Regulatory Issues
From a regulatory perspective, the safety and efficacy of genome editing therapies must be thoroughly evaluated. This includes preclinical and clinical testing to ensure that the editing tools do not cause harmful off-target effects and that they achieve the desired therapeutic outcomes . Regulatory frameworks are evolving to keep pace with the advancements in genome editing technologies.
Conclusion
Therapeutic genome editing holds great promise for treating a wide range of genetic diseases. Advances in technologies like CRISPR/Cas9 have made it possible to precisely edit the human genome, offering new hope for patients with previously untreatable conditions. However, significant challenges remain, particularly in the areas of delivery, ethical considerations, and regulatory approval. Continued research and development are essential to fully realize the potential of therapeutic genome editing and ensure its safe and effective application in clinical settings.
Sources and full results
Most relevant research papers on this topic
Genome-editing Technologies for Gene and Cell Therapy
Genome-editing technologies enable precise manipulation of human genomes for therapeutic effects in gene and cell therapy, offering potential for antiviral strategies, immunotherapies, and treating monogenic hereditary disorders.
The delivery challenge: fulfilling the promise of therapeutic genome editing
Therapeutic genome editing has the potential to treat various diseases, but efficient delivery technologies and optimized genome editing enzymes are needed to fully realize its therapeutic potential.
Implications of human genetic variation on CRISPR-based therapeutic genome editing
Human genetic variation impacts target choice for CRISPR-based therapeutic genome editing, highlighting the need for prescreening through whole-genome sequencing to ensure safety.
Molecular tumor targeting of gelonin by fusion with F3 peptide
Gene-editing therapies show promise for treating various diseases, but precise engineering and delivery of nucleases pose regulatory challenges and safety concerns.
DOI